How should the levothyroxine dose be adjusted for a 56-year-old woman with hypothyroidism taking 75 µg Synthroid (levothyroxine) who has a TSH of 29.8 mIU/L?

Levothyroxine Dose Adjustment for TSH 29.8 mIU/L

Increase the levothyroxine dose by 25 µg (from 75 µg to 100 µg daily) and recheck TSH in 4–8 weeks. 1

Rationale for Dose Increase

A TSH of 29.8 mIU/L indicates severe undertreatment despite the current 75 µg dose. 1 This markedly elevated TSH—far above the normal range of 0.3–4.1 mIU/L—signals inadequate thyroid hormone replacement and requires prompt dose escalation. 2, 3

Recommended Dose Adjustment Strategy

• Increase levothyroxine by 25 µg (to 100 µg daily), which is the standard increment for patients with TSH >12 mIU/L. 1
• The FDA label for Synthroid specifies that dose adjustments are generally made in 12.5–25 µg increments until TSH normalizes. 4
• Given the severity of TSH elevation (29.8 mIU/L), a 25 µg increase is appropriate to achieve more rapid normalization. 1

Monitoring After Dose Change

• Recheck TSH in 4–8 weeks after the dose increase, as levothyroxine has a long half-life and peak therapeutic effect may not be attained for 4–6 weeks. 1, 4
• Continue adjusting the dose in 12.5–25 µg increments every 4–8 weeks until TSH falls within the target range of 0.3–4.1 mIU/L. 1, 5
• Once TSH is stable in the normal range, monitor every 6 months, then annually. 1, 5

Critical Considerations Before Dose Escalation

Verify Medication Adherence and Absorption

• Non-compliance is the most common cause of persistently elevated TSH in treated patients; confirm the patient is taking levothyroxine consistently before increasing the dose. 3, 5
• Ensure levothyroxine is taken 30–60 minutes before breakfast on an empty stomach with water to maximize absorption. 1, 5
• Separate levothyroxine from calcium, iron, proton-pump inhibitors, and bile-acid sequestrants by at least 4 hours, as these interfere with absorption. 5
• Approximately 70% of oral levothyroxine is absorbed; concurrent food or interfering medications markedly reduce bioavailability. 1, 5

Age and Cardiac Risk Assessment

• At 56 years of age, this patient falls into the category where gradual dose increases are recommended if there is any underlying cardiac disease. 1
• For patients ≥50 years without known coronary disease, the American Association of Clinical Endocrinologists (AACE) and American Thyroid Association (ATA) recommend starting at 50 µg daily and increasing by 12.5–25 µg every 6–8 weeks. 1, 4
• Screen for cardiac symptoms (angina, palpitations, atrial fibrillation) before and after each dose increase, especially in older patients. 5, 4
• If the patient has known coronary heart disease, use smaller increments (12.5 µg) and monitor closely for ischemic symptoms. 4

Exclude Malabsorption and Drug Interactions

• If TSH remains elevated despite doses >200 µg/day, suspect non-compliance or malabsorption rather than further dose escalation. 5
• Review medications that may interfere with levothyroxine absorption or metabolism (see Table 10 in guidelines: glucocorticoids, amiodarone, propylthiouracil, beta-blockers, iodinated contrast). 1
• When absorption-interfering drugs are added or discontinued, recheck TSH within 4–8 weeks. 1

Target TSH Goals

• The therapeutic target for most adults is TSH 0.3–4.1 mIU/L, with many clinicians preferring the lower half of this range (0.4–2.5 mIU/L). 5, 6
• For patients 60–80 years, target TSH 1–8 mIU/L, maintaining >1 mIU/L to avoid iatrogenic thyrotoxicosis. 2, 5
• There is no evidence to support targeting specific TSH values within the normal range, except in pregnancy. 1

Common Pitfalls to Avoid

• Do not ignore a markedly elevated TSH simply because the patient may feel asymptomatic; undertreatment increases cardiovascular risk and metabolic dysfunction. 2, 3
• Avoid overtreatment: approximately 20% of patients on levothyroxine are overtreated, leading to atrial fibrillation, accelerated bone loss, and increased mortality. 2, 5
• Do not increase the dose too rapidly in elderly patients or those with cardiac disease, as this raises the risk of atrial fibrillation and angina. 5, 4
• Before raising levothyroxine, exclude adrenal insufficiency when TSH is high, as untreated adrenal disease can precipitate a dangerous thyroid hormone surge. 3, 5

Special Considerations for This Patient

• At 56 years old, this patient is in the age range where gradual dose titration is preferred if there is any suspicion of cardiac disease. 1, 4
• If the patient has been on 75 µg for an extended period with good compliance, the markedly elevated TSH suggests either worsening thyroid function (progression of autoimmune thyroiditis) or new malabsorption/drug interaction. 1
• Consider checking thyroid peroxidase antibodies if not previously done, as positive antibodies predict progression to overt hypothyroidism. 6

Follow-Up Algorithm

1. Increase levothyroxine to 100 µg daily (25 µg increment). 1
2. Recheck TSH in 6–8 weeks (allow full 8 weeks if using smaller increments). 1
3. If TSH remains >10 mIU/L, increase by another 12.5–25 µg. 1, 4
4. If TSH is 4.1–10 mIU/L, increase by 12.5 µg. 1
5. If TSH is 0.3–4.1 mIU/L, maintain current dose and recheck in 6 months. 1, 5
6. If TSH is <0.3 mIU/L, reduce dose by 12.5 µg and recheck in 4–8 weeks. 4